NCT05916196View on ClinicalTrials.gov

[18F]FES PET/.CT in Uterine Cancer

PHASE2RecruitingINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

April 5, 2024

Primary Completion Date

August 1, 2026

Study Completion Date

August 1, 2027

Conditions

Uterine Cancer

Interventions

DRUG

18F-Fluoroestradiol

18F-FES PET/CT

Trial Locations (1)

19104

RECRUITING

Abramson Cancer Center at University of Pennsylvania, Philadelphia

All Listed Sponsors

lead

Abramson Cancer Center at Penn Medicine

OTHER